LON:CVSG CVS Group (CVSG) Share Price, News & Analysis GBX 848 +11.00 (+1.31%) (As of 12:05 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades About CVS Group Stock (LON:CVSG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CVS Group alerts:Sign Up Key Stats Today's Range 831▼ 85350-Day Range 798▼ 1,05652-Week Range 791▼ 1,749Volume150,480 shsAverage Volume306,712 shsMarket Capitalization£608.36 millionP/E Ratio2,332.72Dividend Yield0.94%Price TargetGBX 2,370Consensus RatingBuy Company OverviewCVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste disposal services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.Read More… CVS Group Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks37th Percentile Overall ScoreCVSG MarketRank™: CVS Group scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCVS Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCVS Group has received no research coverage in the past 90 days.Read more about CVS Group's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CVS Group is 2,332.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 135.02.Price to Earnings Ratio vs. SectorThe P/E ratio of CVS Group is 2,332.72, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 391.33.Price to Earnings Growth RatioCVS Group has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCVS Group has a P/B Ratio of 2.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CVSG. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldCVS Group has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCVS Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CVS Group is 2,222.22%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about CVS Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for CVSG. News and Social Media2.1 / 5News SentimentN/A News SentimentCVS Group has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 1 news article for CVS Group this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for CVSG on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added CVS Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CVS Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.83% of the stock of CVS Group is held by insiders.Percentage Held by Institutions70.22% of the stock of CVS Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVS Group's insider trading history. Receive CVSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVS Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CVSG Stock News HeadlinesCVS Group Regulatory NewsNovember 22, 2024 | lse.co.ukCVS Group Share Chat (CVSG)November 22, 2024 | lse.co.ukWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.December 18, 2024 | Behind the Markets (Ad)CVS Group's (LON:CVSG) Returns On Capital Are Heading HigherNovember 21, 2024 | nz.finance.yahoo.comJ.P. Morgan Reaffirms Their Buy Rating on CVS Health (CVS)November 13, 2024 | markets.businessinsider.comCVS Health: Buy Rating with Projected EPS Growth and Strategic Optimism Amid Retail ChallengesNovember 11, 2024 | markets.businessinsider.comCVS names former UnitedHealth exec to run Aetna, shares jumpNovember 8, 2024 | msn.comCVS Health gains after Q3 beat; adds former UnitedHealth exec. to run AetnaNovember 6, 2024 | msn.comSee More Headlines CVSG Stock Analysis - Frequently Asked Questions How have CVSG shares performed this year? CVS Group's stock was trading at GBX 1,683 at the start of the year. Since then, CVSG shares have decreased by 49.6% and is now trading at GBX 848. View the best growth stocks for 2024 here. How were CVS Group's earnings last quarter? CVS Group plc (LON:CVSG) issued its earnings results on Friday, September, 29th. The company reported $42.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $42.30 by $0.50. The business earned $271.80 million during the quarter. CVS Group had a trailing twelve-month return on equity of 10.21% and a net margin of 0.96%. How do I buy shares of CVS Group? Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of CVS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Group investors own include Meta Platforms (META), Salesforce (CRM), NVIDIA (NVDA), Pfizer (PFE), QUALCOMM (QCOM), AbbVie (ABBV) and Walt Disney (DIS). Company Calendar Last Earnings9/29/2017Ex-Dividend for 11/29 Dividend10/31/2024Dividend Payable11/29/2024Today12/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Personal Services Sub-IndustryN/A Current SymbolLON:CVSG CUSIPN/A CIKN/A Webwww.cvsukltd.co.uk Phone+44-1379-644288FaxN/AEmployees9,100Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 2,370 High Stock Price TargetGBX 2,370 Low Stock Price TargetGBX 2,370 Potential Upside/Downside+179.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.36 Trailing P/E Ratio2,358.33 Forward P/E Ratio9.04 P/E Growth1.77Net Income£26.20 million Net Margins0.96% Pretax MarginN/A Return on Equity10.21% Return on Assets5.03% Debt Debt-to-Equity Ratio110.48 Current Ratio1.09 Quick Ratio0.90 Sales & Book Value Annual Sales£647.30 million Price / Sales0.94 Cash FlowGBX 27.99 per share Price / Cash Flow30.33 Book ValueGBX 363 per share Price / Book2.34Miscellaneous Outstanding Shares71,740,000Free FloatN/AMarket Cap£609.07 million OptionableNot Optionable Beta1.02 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (LON:CVSG) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.